Why Salesforce (CRM) Stock Is Down Today
Investivoq PriceTracker
Salesforce (CRM) is down 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The clearest near-term explanation is that today’s decline looks more like a reversal and profit-taking move than a reaction to a new company-specific setback. This could be because broader tech shares were under pressure, while Salesforce had just rallied earlier in the week after a major analyst upgrade, leaving the stock vulnerable to a pullback.
Details:
Sources:
AP News, Kiplinger, Salesforce Investor Relations
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CRM Insider Trading Activity
$CRM insiders have traded $CRM stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:
- CRAIG CONWAY has made 0 purchases and 2 sales selling 4,500 shares for an estimated $1,172,746.
- DAVID BLAIR KIRK purchased 4,176 shares for an estimated $999,450
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$CRM Hedge Fund Activity
We have seen 1,008 institutional investors add shares of $CRM stock to their portfolio, and 1,581 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 10,440,961 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,635,680,950
- MORGAN STANLEY removed 8,364,287 shares (-26.4%) from their portfolio in Q2 2026, for an estimated $1,310,349,201
- CAPITAL WORLD INVESTORS removed 8,024,160 shares (-48.0%) from their portfolio in Q2 2026, for an estimated $1,257,064,905
- BLACKROCK, INC. removed 6,942,275 shares (-8.7%) from their portfolio in Q2 2026, for an estimated $1,087,576,801
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 6,600,642 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,034,056,575
- ALYESKA INVESTMENT GROUP, L.P. added 4,662,005 shares (+inf%) to their portfolio in Q2 2026, for an estimated $730,349,703
- CAPITAL INTERNATIONAL INVESTORS removed 4,472,425 shares (-35.4%) from their portfolio in Q2 2026, for an estimated $700,650,100
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$CRM Congressional Stock Trading
Members of Congress have traded $CRM stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 1 purchase worth up to $50,000 on 06/02 and 1 sale worth up to $15,000 on 09/24.
To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.
$CRM Price Targets
Multiple analysts have issued price targets for $CRM recently. We have seen 20 analysts offer price targets for $CRM in the last 6 months, with a median target of $226.5.
Here are some recent targets:
- John Difucci from Guggenheim set a target price of $228.0 on 07/01/2026
- Scott Berg from Needham set a target price of $400.0 on 06/16/2026
- David Hynes from Canaccord Genuity set a target price of $225.0 on 06/16/2026
- Tyler Radke from Citigroup set a target price of $187.0 on 05/28/2026
- Mark Moerdler from Bernstein set a target price of $173.0 on 05/28/2026
- Patrick Walravens from Citizens set a target price of $315.0 on 05/28/2026
- Michael Turrin from Wells Fargo set a target price of $200.0 on 05/28/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.